Source: BioSpace

M2S: M2S and NAMSA Collaboration to Nest Pre-market Vascular Device Trials in Registries

A strategic collaboration has been established to combine the medical registry services of M2S, a division of Medstreaming, with the Contract Research Organization (CRO) expertise of NAMSA, to provide more efficient clinical trial services for vascular device manufacturers.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Greg Lange's photo - CEO of M2S

CEO

Greg Lange

CEO Approval Rating

69/100

Read more